Angeles Wealth Management LLC Sells 407 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Angeles Wealth Management LLC lessened its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 8.8% in the fourth quarter, Holdings Channel.com reports. The firm owned 4,197 shares of the medical equipment provider’s stock after selling 407 shares during the period. Angeles Wealth Management LLC’s holdings in Intuitive Surgical were worth $2,191,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. M.E. Allison & CO. Inc. acquired a new stake in Intuitive Surgical in the 4th quarter valued at approximately $449,000. Seilern Investment Management Ltd bought a new position in shares of Intuitive Surgical during the 4th quarter worth approximately $82,517,000. Exome Asset Management LLC raised its holdings in shares of Intuitive Surgical by 16.8% in the third quarter. Exome Asset Management LLC now owns 7,427 shares of the medical equipment provider’s stock valued at $3,649,000 after purchasing an additional 1,069 shares during the last quarter. China Universal Asset Management Co. Ltd. lifted its position in shares of Intuitive Surgical by 5.6% in the fourth quarter. China Universal Asset Management Co. Ltd. now owns 9,843 shares of the medical equipment provider’s stock worth $5,138,000 after purchasing an additional 525 shares in the last quarter. Finally, Consolidated Planning Corp boosted its holdings in Intuitive Surgical by 17.4% during the third quarter. Consolidated Planning Corp now owns 8,099 shares of the medical equipment provider’s stock worth $3,979,000 after purchasing an additional 1,198 shares during the last quarter. Institutional investors and hedge funds own 83.64% of the company’s stock.

Analysts Set New Price Targets

Several brokerages have commented on ISRG. Morgan Stanley raised shares of Intuitive Surgical from an “equal weight” rating to an “overweight” rating and boosted their price target for the stock from $522.00 to $650.00 in a research report on Monday, December 2nd. BTIG Research upped their target price on Intuitive Surgical from $535.00 to $561.00 and gave the stock a “buy” rating in a report on Tuesday, November 26th. Mizuho raised their price target on Intuitive Surgical from $440.00 to $500.00 in a research note on Thursday, October 17th. Citigroup boosted their price target on Intuitive Surgical from $640.00 to $711.00 and gave the stock a “buy” rating in a research report on Friday, January 24th. Finally, Jefferies Financial Group increased their price objective on Intuitive Surgical from $475.00 to $575.00 in a report on Monday, January 27th. One analyst has rated the stock with a sell rating, five have given a hold rating and sixteen have given a buy rating to the company’s stock. According to MarketBeat, Intuitive Surgical currently has a consensus rating of “Moderate Buy” and a consensus target price of $613.10.

Intuitive Surgical Price Performance

ISRG stock opened at $582.98 on Monday. The business’s fifty day moving average price is $554.85 and its two-hundred day moving average price is $514.38. The stock has a market capitalization of $207.65 billion, a price-to-earnings ratio of 90.95, a PEG ratio of 5.67 and a beta of 1.39. Intuitive Surgical, Inc. has a fifty-two week low of $364.17 and a fifty-two week high of $616.00.

Insider Buying and Selling

In other Intuitive Surgical news, CFO Jamie Samath sold 94 shares of the firm’s stock in a transaction on Wednesday, January 29th. The stock was sold at an average price of $571.11, for a total transaction of $53,684.34. Following the transaction, the chief financial officer now owns 2,630 shares in the company, valued at $1,502,019.30. This trade represents a 3.45 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Amal M. Johnson sold 4,635 shares of the company’s stock in a transaction on Tuesday, January 28th. The shares were sold at an average price of $566.60, for a total value of $2,626,191.00. Following the sale, the director now owns 12,275 shares of the company’s stock, valued at approximately $6,955,015. The trade was a 27.41 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders have sold 5,671 shares of company stock valued at $3,188,254. 0.90% of the stock is owned by company insiders.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.